Ken Griffin Biora Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.13 - $12.03 $1,326 - $122,706
-10,200 Reduced 9.03%
102,700 $13,000
Q3 2022

Nov 14, 2022
SELL
$0.53 - $13.3 $93,545 - $2.35 Million
-176,500 Reduced 60.99%
112,900 $55,000

Others Institutions Holding BIOR

# of Institutions
2
Shares Held
890
Call Options Held
0
Put Options Held
0
View Full List

About BIORA THERAPEUTICS, INC.

BIOR Quotes by TradingView
  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $299M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email